Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Melatonin Supplementation Attenuates the Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice Induced by A High-Fat Diet.
Farias TDSM
,
Paixao RID
,
Cruz MM
,
de Sa RDCDC
,
Simão JJ
,
Antraco VJ
,
Alonso-Vale MIC
.
???displayArticle.abstract???
Obesity is defined as a condition of abnormal or excessive fat accumulation in white adipose tissue that results from the exacerbated consumption of calories associated with low energy expenditure. Fat accumulation in both adipose tissue and other organs contributes to a systemic inflammation leading to the development of metabolic disorders such as type 2 diabetes, hypertension, and dyslipidemia. Melatonin is a potent antioxidant and improves inflammatory processes and energy metabolism. Using male mice fed a high-fat diet (HFD-59% fat from lard and soybean oil; 9:1) as an obesity model, we investigated the effects of melatonin supplementation on the prevention of obesity-associated complications through an analysis of plasma biochemical profile, body and fat depots mass, adipocytes size and inflammatory cytokines expression in epididymal (EPI) adipose depot. Melatonin prevented a gain of body weight and fat depot mass as well as adipocyte hypertrophy. Melatonin also reversed the increase of total cholesterol, triglycerides and LDL-cholesterol. In addition, this neurohormone was effective in completely decreasing the inflammatory cytokines leptin and resistin in plasma. In the EPI depot, melatonin reversed the increase of leptin, Il-6, Mcp-1 and Tnf-α triggered by obesity. These data allow us to infer that melatonin presents an anti-obesity effect since it acts to prevent the progression of pro-inflammatory markers in the epididymal adipose tissue together with a reduction in adiposity.
Alonso-Vale,
Light/dark cycle-dependent metabolic changes in adipose tissue of pinealectomized rats.
2004, Pubmed
Alonso-Vale,
Light/dark cycle-dependent metabolic changes in adipose tissue of pinealectomized rats.
2004,
Pubmed
Alonso-Vale,
Melatonin enhances leptin expression by rat adipocytes in the presence of insulin.
2005,
Pubmed
Ayonrinde,
Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
2011,
Pubmed
Bastard,
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
2006,
Pubmed
Bolsoni-Lopes,
Palmitoleic acid (n-7) increases white adipocyte lipolysis and lipase content in a PPARα-dependent manner.
2013,
Pubmed
Borges-Silva,
Pinealectomy reduces hepatic and muscular glycogen content and attenuates aerobic power adaptability in trained rats.
2007,
Pubmed
Bucolo,
Quantitative determination of serum triglycerides by the use of enzymes.
1973,
Pubmed
Cancello,
Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.
2006,
Pubmed
Crewe,
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
2017,
Pubmed
Cuesta,
Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8).
2010,
Pubmed
Engin,
Circadian Rhythms in Diet-Induced Obesity.
2017,
Pubmed
Fasshauer,
Adipokines in health and disease.
2015,
Pubmed
Favero,
Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice.
2015,
Pubmed
Fontana,
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.
2007,
Pubmed
Fox,
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.
2007,
Pubmed
Franssen,
Obesity and dyslipidemia.
2011,
Pubmed
Graham,
Dyslipidemias in the prevention of cardiovascular disease: risks and causality.
2012,
Pubmed
Greenberg,
Obesity and the role of adipose tissue in inflammation and metabolism.
2006,
Pubmed
Gómez-Ambrosi,
Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy.
2014,
Pubmed
Ha,
Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells.
2006,
Pubmed
Hadjzadeh,
THE EFFECT OF MELATONIN AGAINST GASTRIC OXIDATIVE STRESS AND DYSLIPIDEMIA IN STREPTOZOTOCIN-INDUCED DIABETIC RATS.
2018,
Pubmed
Halpern,
Melatonin Increases Brown Adipose Tissue Volume and Activity in Patients With Melatonin Deficiency: A Proof-of-Concept Study.
2019,
Pubmed
Holmes,
Proceedings: The effect of melatonin on pinealectomy-induced hypertension in the rat.
1976,
Pubmed
Hotamisligil,
Inflammation and metabolic disorders.
2006,
Pubmed
Hoyos,
Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats.
2000,
Pubmed
Hussein,
Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model.
2007,
Pubmed
Izzo,
Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000.
1981,
Pubmed
Kaneko,
Obesity alters circadian expressions of molecular clock genes in the brainstem.
2009,
Pubmed
Kohsaka,
High-fat diet disrupts behavioral and molecular circadian rhythms in mice.
2007,
Pubmed
Lancha,
Peripheral signalling involved in energy homeostasis control.
2012,
Pubmed
Lima,
Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats.
1998,
Pubmed
Lima,
The regulation of insulin action in isolated adipocytes. Role of the periodicity of food intake, time of day and melatonin.
1994,
Pubmed
Livak,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
2001,
Pubmed
Loloei,
The effect of melatonin supplementation on lipid profile and anthropometric indices: A systematic review and meta-analysis of clinical trials.
2019,
Pubmed
López-Jaramillo,
The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
2014,
Pubmed
McNelis,
Macrophages, immunity, and metabolic disease.
2014,
Pubmed
Mesri Alamdari,
A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women.
2015,
Pubmed
Nduhirabandi,
Short-term melatonin consumption protects the heart of obese rats independent of body weight change and visceral adiposity.
2014,
Pubmed
Nogueira,
Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response.
2011,
Pubmed
Ouchi,
Adipokines in inflammation and metabolic disease.
2011,
Pubmed
Owino,
Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity.
2018,
Pubmed
Pan,
Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
2006,
Pubmed
Pfeffer,
Synchronizing effects of melatonin on diurnal and circadian rhythms.
2018,
Pubmed
Picinato,
Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat.
2002,
Pubmed
Postiglione,
[Determination of serum and lipoprotein phospholipids by a new enzymatic colorimetric method: characterization of a "reference range" in a sample of clinically healthy people].
1982,
Pubmed
RODBELL,
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.
1964,
Pubmed
Ríos-Lugo,
Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.
2010,
Pubmed
She,
NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats.
2009,
Pubmed
Sun,
Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
2016,
Pubmed
Szewczyk-Golec,
Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity.
2015,
Pubmed
Weisberg,
Obesity is associated with macrophage accumulation in adipose tissue.
2003,
Pubmed
Xu,
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
2003,
Pubmed
Yadav,
Role of leptin and adiponectin in insulin resistance.
2013,
Pubmed
Zalatan,
Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism.
2001,
Pubmed
Zanoboni,
Effect of pinealectomy on arterial blood pressure and food and water intake in the rat.
1978,
Pubmed
Zanquetta,
Body weight, metabolism and clock genes.
2010,
Pubmed
de Farias,
Pinealectomy interferes with the circadian clock genes expression in white adipose tissue.
2015,
Pubmed
de Oliveira,
Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment.
2012,
Pubmed
de Sá,
Fish oil prevents changes induced by a high-fat diet on metabolism and adipokine secretion in mice subcutaneous and visceral adipocytes.
2016,
Pubmed
,
Echinobase
